BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10508302)

  • 1. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Jhooti P; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Cardiovasc Magn Reson; 1999; 1(1):23-32. PubMed ID: 11550338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection.
    Bjerner T; Wikström G; Johansson L; Ahlström H
    Invest Radiol; 2004 Aug; 39(8):470-8. PubMed ID: 15257208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal T(*)(2) perfusion using an iron oxide nanoparticle contrast agent--influence of T(1) relaxation on the first-pass response.
    Bjørnerud A; Johansson LO; Ahlström HK
    Magn Reson Med; 2002 Feb; 47(2):298-304. PubMed ID: 11810673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal vessel enhancement with an ultrasmall, superparamagnetic iron oxide blood pool agent: evaluation of dose and echo time dependence at different field strengths.
    Wikström LJ; Johansson LO; Ericsson BA; Börseth A; Akeson PA; Ahlström KH
    Acad Radiol; 1999 May; 6(5):292-8. PubMed ID: 10228618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
    Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
    J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.
    Small WC; Nelson RC; Bernardino ME
    Magn Reson Imaging; 1993; 11(5):645-54. PubMed ID: 8345779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma.
    Ichikawa T; Arbab AS; Araki T; Touyama K; Haradome H; Hachiya J; Yamaguchi M; Kumagai H; Aoki S
    AJR Am J Roentgenol; 1999 Jul; 173(1):207-13. PubMed ID: 10397128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hemorrhage: imaging with a new magnetic resonance blood pool agent in conjunction with breathheld three-dimensional magnetic resonance angiography.
    Weishaupt D; Hilfiker PR; Schmidt M; Debatin JF
    Cardiovasc Intervent Radiol; 1999; 22(4):321-5. PubMed ID: 10415223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
    Coenegrachts K; Orlent H; ter Beek L; Haspeslagh M; Bipat S; Stoker J; Rigauts H
    J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model.
    Bjerner T; Ericsson A; Wikström G; Johansson L; Nilsson S; Ahlström H; Hemmingsson A
    J Magn Reson Imaging; 2000 Dec; 12(6):866-72. PubMed ID: 11105024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
    Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
    J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional cardiac cine magnetic resonance imaging with an ultrasmall superparamagnetic iron oxide blood pool agent (NC100150).
    Amano Y; Herfkens RJ; Shifrin RY; Alley MT; Pelc NJ
    J Magn Reson Imaging; 2000 Feb; 11(2):81-6. PubMed ID: 10713938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.